Connect Biopharma Holdings Limited (CNTB) vs eXoZymes, Inc. (EXOZ)
A side-by-side comparison of Connect Biopharma Holdings Limited and eXoZymes, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.91HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
EXOZ
eXoZymes, Inc.
$5.72HealthcareDelayed quote: Oct 6, 2026, 10:42 AM EDT
Total return — CNTB vs EXOZ
growth of $100 · dividends reinvested · last 2yCNTB -10.2% (-5.2%/yr)EXOZ -36.2% (-20.1%/yr)CNTB compounded faster over this window
CNTB EXOZ
CNTB vs EXOZ: by the numbers
- •CNTB is the larger company ($57M vs $53M market cap).
- •Both run net losses; EXOZ's is the smaller (0.00% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | EXOZ |
|---|---|---|
| P/B ratio | 2.14 | 14.53 |
Profitability
| Metric | CNTB | EXOZ |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -90740.62% | 0.00% |
| Net margin | -86687.50% | 0.00% |
| ROE | -132.16% | -278.89% |
| ROIC | -136.77% | -157.40% |
Growth (annualized)
| Metric | CNTB | EXOZ |
|---|---|---|
| Total return CAGR (5Y) | -47.22% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.